Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Abiraterone Acetate × Prednisolone × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 11 Lymphoma 11 Prostatic Neoplasms 9 Lymphoma, Large B-Cell, Diffuse 8 Lymphoma, Follicular 7 Leukemia 7 Lymphoma, Non-Hodgkin 6 Burkitt Lymphoma 5 Hodgkin Disease 4 Neoplasm Metastasis 3 Lymphoma, Large-Cell, Immunoblastic 3 Dendritic Cell Sarcoma, Interdigitating 3 Multiple Myeloma 2 Urogenital Neoplasms 1 Thymoma 1 Recurrence 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Neurotoxicity Syndromes 1 Neoplasms, Plasma Cell 1 Neoplasms 1 Myasthenia Gravis 1 Metastatic Castration-resistant Prostate Cancer 1 Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Leukemia, Biphenotypic, Acute 1 Hemangioma 1 Heart Failure 1 Drug-Related Side Effects and Adverse Reactions 1

Interventions

Prednisolone 1 BID protein, human 1 Androgen Antagonists 1 Abiraterone Acetate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06768255 2025-01-10

mCRPC

Fudan University

Phase 3 Not yet recruiting

Abiraterone Acetate

Data powered by HemOnc (CC BY 4.0) Colophon ⚡